Exane Derivatives’s American Tower AMT Stock Holding History

Exane Derivatives’s Portfolio AMT Stock Details AMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$421K	Sell	1,646 -375	-19%	-$94.1K	0.24%	105
2022 Q1	$508K	Sell	2,021 -412	-17%	-$101K	0.14%	183
2021 Q4	$712K	Sell	2,433 -396	-14%	-$108K	0.17%	133
2021 Q3	$751K	Buy	2,829 +887	+46%	+$253K	0.18%	123
2021 Q2	$541K	Buy	1,942 +1,646	+556%	+$419K	0.12%	172
2021 Q1	$70.8K	Sell	296 -514	-63%	-$114K	0.02%	477
2020 Q4	$182K	Buy	810 +603	+291%	+$140K	0.05%	319
2020 Q3	$50K	Sell	207 -490	-70%	-$124K	0.01%	373
2020 Q2	$180K	Buy	697 +694	+23,133%	+$172K	0.05%	221
2020 Q1	$653	Sell	3 -10	-77%	-$2.33K	﹤0.01%	566
2019 Q4	$3.06K	Sell	13 -917	-99%	-$200K	﹤0.01%	466
2019 Q3	$206K	Sell	930 -65	-7%	-$14.2K	0.04%	255
2019 Q2	$203K	Buy	995 +980	+6,533%	+$197K	0.04%	264
2019 Q1	$2.96K	Buy	15 +2	+15%	+$351	﹤0.01%	427
2018 Q4	$2.06K	Hold	13	–	–	﹤0.01%	523
2018 Q3	$1.88K	Sell	13 -1	-7%	-$147	﹤0.01%	500
2018 Q2	$2.02K	Buy	14 +1	+8%	+$139	﹤0.01%	495
2018 Q1	$1.9K	Sell	13 -3,170	-100%	-$447K	﹤0.01%	452
2017 Q4	$454K	Sell	3,183 -1,444	-31%	-$206K	0.08%	172
2017 Q3	$632K	Sell	4,627 -438	-9%	-$61K	0.12%	122
2017 Q2	$670K	Sell	5,065 -1,212	-19%	-$155K	0.14%	114
2017 Q1	$763K	Sell	6,277 -1,173	-16%	-$129K	0.17%	102
2016 Q4	$787K	Buy	7,450 +23	+0.3%	+$2.5K	0.16%	105
2016 Q3	$842K	Buy	7,427 +7,105	+2,207%	+$812K	0.13%	103
2016 Q2	$36.6K	Sell	322 -1,558	-83%	-$166K	0.01%	296
2016 Q1	$192K	Sell	1,880 -388	-17%	-$36.3K	0.03%	197
2015 Q4	$220K	Sell	2,268 -2,644	-54%	-$258K	0.03%	157
2015 Q3	$432K	Buy	4,912 +2,515	+105%	+$237K	0.05%	134
2015 Q2	$224K	Buy	2,397 +511	+27%	+$48.3K	0.02%	204
2015 Q1	$178K	Buy	1,886 +1,610	+583%	+$157K	0.02%	216
2014 Q4	$27.3K	Buy	+276	New	+$27.1K	﹤0.01%	364

Other funds holding AMT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Exane Derivatives's AMT Position: Q2 2022 in Review

Exane Derivatives reduced its American Tower (AMT) stake by 19% in Q2 2022, selling an estimated $94.1K and leaving 1,646 shares worth $421K. The position accounts for 0.24% of the portfolio, ranked #105.

Exane Derivatives first reported a position in AMT in Q4 2014 and has held it in 31 quarters since. The position peaked at $842K in Q3 2016. 1,744 funds tracked by Wall St. Rank hold AMT as of Q2 2022.

Exane Derivatives held 1,646 shares of American Tower worth $421K as of Q2 2022.
Exane Derivatives sold 375 American Tower shares in Q2 2022, an estimated $94.1K.
American Tower made up 0.24% of Exane Derivatives's portfolio in Q2 2022, its #105 holding.
Exane Derivatives first reported a position in American Tower in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's American Tower position peaked at $842K in Q3 2016.
1,744 funds tracked by Wall St. Rank held American Tower as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.